Biotricity, Inc. ( BTCY) - Key Metrics
BTCY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.14 | -$0.04 | -$0.03 | -$0.03 |
| 2026Q2 | $0.15 | -$0.03 | $0.02 | $0.02 |
| 2026Q1 | $0.15 | -$0.03 | -$0.01 | -$0.01 |
| 2025Q4 | $0.16 | -$0.08 | -$0.02 | -$0.02 |
| 2025Q3 | $0.15 | -$0.05 | $0 | $0 |
BTCY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | -0.52% | -1.80 |
| 2026Q2 | -0.89% | -5.04 |
| 2026Q1 | -0.88% | -3.62 |
| 2025Q4 | -0.32% | -1.00 |
| 2025Q3 | -0.48% | -1.43 |
BTCY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -8.94% | 0.07% |
| 2026Q2 | 2.98% | 0.04% |
| 2026Q1 | -3.84% | 0.06% |
| 2025Q4 | -5.15% | 0.08% |
| 2025Q3 | -1.25% | 0.08% |
BTCY
Price: $0.12
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.16 USD
P/E Ratio: -1.87
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 195900
Market Capitalization: 3.7 million